OCUL- Ocular Therapeutix, Inc.

Name: Ocular Therapeutix, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ocular Therapeutix, Inc. (OCUL) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Dugel Pravin	2.62M	$25.24M	-
Other	Notman Donald	389.3K	$3.75M	-
Other	Nayak Sanjay	330.7K	$3.19M	-
Other	Waheed Nadia	326.3K	$3.15M	-
Other	Heier Jeffrey S.	323.4K	$3.12M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 23, 2026	Dugel Pravin	See Remarks	Sell	20,056	$8.28	$166,063.68	-0.7%	-	-
Feb 23, 2026	Nayak Sanjay	Chief Strategy Officer	Sell	1,759	$8.28	$14,564.52	-0.5%	-	-
Feb 23, 2026	Kaiser Peter	Chief Development Officer	Sell	2,810	$8.28	$23,266.80	-1.0%	-	-
Feb 23, 2026	Heier Jeffrey S.60	Chief Scientific Officer	Sell	3,057	$8.28	$25,311.96	-0.9%	-	-
Nov 24, 2025	Nayak Sanjay	Chief Strategy Officer	Sell	1,878	$12.04	$22,611.12	-0.7%	-30.4%	-
Nov 24, 2025	Dugel Pravin	See Remarks	Sell	19,530	$12.04	$235,141.20	-0.6%	-30.4%	-
Nov 24, 2025	Kaiser Peter	Chief Development Officer	Sell	3,007	$12.02	$36,144.14	-1.5%	-30.4%	-
Nov 24, 2025	Heier Jeffrey S.60	Chief Scientific Officer	Sell	3,469	$12.04	$41,766.76	-1.4%	-30.4%	-
Nov 5, 2025	Saroj Namrata	Chief Business Officer	Sell	25,865	$10.74	$277,790.10	-12.9%	-21.3%	-
Oct 8, 2025	Anderman Todd	Chief Legal Officer	Sell	11,132	$12.34	$137,368.88	-11.3%	-5.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC